Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures

Xiaoming Ju, Adam Ertel, Mathew C. Casimiro, Zuoren Yu, Hui Meng, Peter A. McCue, Rhonda Walters, Paolo Fortina, Michael P. Lisanti, Richard G. Pestell

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Herein, murine prostate cancer cell lines, generated via selective transduction with a single oncogene (c-Myc, Ha-Ras, and v-Src), showed oncogene-specific prostate cancer molecular signatures that were recapitulated in human prostate cancer and developed lung metastasis in immune-competent mice. Interrogation of two independent retrospective cohorts of patient samples using the oncogene signature showed an ability to distinguish tumor from normal prostate with a predictive value for prostate cancer of 98% to 99%. In a blinded study, the signature algorithm showed independent substratification of reduced recurrence-free survival by Kaplan-Meier analysis. The generation of new oncogene-specific prostate cancer cell lines that recapitulate human prostate cancer gene expression, which metastasize in immune-competent mice, are a valuable new resource for testing targeted therapy, whereas the molecular signatures identified herein provides further value over current gene signature markers of prediction and outcome. © 2012 AACR.
    Original languageEnglish
    Pages (from-to)978-989
    Number of pages11
    JournalCancer Research
    Volume73
    Issue number2
    DOIs
    Publication statusPublished - 15 Jan 2013

    Fingerprint

    Dive into the research topics of 'Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures'. Together they form a unique fingerprint.

    Cite this